wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q21129230-2B6069EE-E809-4CC1-9E51-4F292162F4FF
Q21129230-2B6069EE-E809-4CC1-9E51-4F292162F4FF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q21129230-2B6069EE-E809-4CC1-9E51-4F292162F4FF
Genetic determinants and potential therapeutic targets for pancreatic adenocarcinoma
P2860
Q21129230-2B6069EE-E809-4CC1-9E51-4F292162F4FF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q21129230-2B6069EE-E809-4CC1-9E51-4F292162F4FF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3933603744e2e12883f67b340936c23a5bffe049
P2860
Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression.